COTY.NYSECoty INC

10-Q: Coty Reports Q1 Revenue Decline Amid Strategic Review

Sentiment:

Quarterly Report


Coty Inc. reported a 6% decrease in net revenues for the first fiscal quarter of 2026, driven by declines across both Prestige and Consumer Beauty segments, while initiating a strategic review of its Consumer Beauty business.

Capital raiseOn October 15, 2025, the company issued an aggregate principal of $900.0 million of 5.600% senior notes due 2031 in a private offering, receiving net proceeds of $888.0 million.The proceeds from this offering were used to redeem the remaining $350.0 million outstanding under the 2026 Dollar Senior Secured Notes and 450.0 million (approximately $520.0 million) of the 2026 Euro Senior Secured Notes on October 17, 2025.
Worse than expectedNet revenues decreased by 6% overall, indicating a decline in sales performance.Operating income decreased by 22%, and operating margin declined by 250 basis points, reflecting reduced profitability.Net income attributable to Coty Inc. decreased by 18%, and diluted EPS fell from $0.09 to $0.07.The Consumer Beauty segment recorded an operating loss of $7.7 million, a significant deterioration from an operating income of $14.0 million in the prior year.Gross margin decreased by 100 basis points due to increased manufacturing, material, and freight costs.The company incurred a $53.9 million cash payment for Hedge Valuation Adjustments due to a decline in its Class A share price, indicating adverse market movements for its stock.

Summary

  • Net revenues for the three months ended September 30, 2025, decreased by 6% to $1,577.2 million, down from $1,671.5 million in the prior year period.
  • Operating income fell 22% to $185.0 million, with the operating margin decreasing to 11.7% from 14.2% year-over-year.
  • Net income attributable to Coty Inc. was $67.9 million, an 18% decrease from $82.9 million in the same period last year.
  • Diluted earnings per common share decreased to $0.07 from $0.09 in the prior year.
  • Gross margin decreased by approximately 100 basis points to 35.5%, primarily due to increased manufacturing and material costs (60 bps) and higher freight costs (40 bps).
  • Selling, general and administrative expenses as a percentage of net revenues increased by 200 basis points to 50.3%.
  • The company launched a comprehensive strategic review of its Consumer Beauty business, focusing on mass color cosmetics and its Brazil business, to assess alternatives including partnerships, divestitures, and spin-offs.
  • Coty issued $900.0 million of 5.600% senior notes due 2031 on October 15, 2025, and used the proceeds to redeem $350.0 million of 2026 Dollar Senior Secured Notes and approximately $520.0 million of 2026 Euro Senior Secured Notes.
  • The company incurred $53.9 million in Hedge Valuation Adjustments on forward repurchase contracts in August 2025 due to a decline in Class A share price.
  • Cash costs related to the Fixed Cost Reduction Plan are expected to be approximately $80.0 million, split evenly between fiscal 2026 and 2027, with $10.0 million incurred life-to-date as of September 30, 2025.
  • Estimated tariff-related costs, after mitigation, are projected to be $35.0 million through Q1 fiscal 2027, with $30.0 million expected in fiscal 2026 and $5.0 million in Q1 fiscal 2027; $5.0 million was reflected in Q1 fiscal 2026 operating results.

Sentiment

Score: 4

Explanation: The filing indicates a challenging quarter with significant declines in revenue, operating income, and net income. While strategic actions like the Consumer Beauty review and debt refinancing are positive long-term moves, the immediate financial performance is weak, and ongoing legal/tax risks remain. The outlook for Q2 is flat, with growth expected only in H2, suggesting continued near-term headwinds.

Positives

  • Cash used in investing activities decreased to $53.8 million from $77.3 million, primarily due to lower capital expenditures.
  • Cash used in financing activities decreased to $7.6 million from $10.4 million, driven by increased net borrowings on the revolving credit facility.
  • Interest expense, net, decreased by 25% to $46.6 million, primarily due to lower average interest rates and positive impact from cross-currency swaps.
  • Other expense, net, decreased by 28% to $31.3 million, mainly due to lower net losses on forward repurchase contracts.
  • The effective income tax rate decreased to 30.9% from 31.7%, primarily due to lower limitations on the deductibility of executive stock compensation and interest expense.
  • The company's equity investment in Wella saw a net income of $6.1 million for the three months ended September 30, 2025, a significant improvement from a net loss of $26.1 million in the prior year.
  • Successful refinancing of debt post-quarter end, extending maturities and reducing near-term obligations.
  • The company remains in compliance with all covenants contained within the 2018 Coty Credit Agreement as of September 30, 2025.

Negatives

  • Net revenues decreased by 6% overall, with Prestige segment revenues down 4% and Consumer Beauty segment revenues down 9%.
  • Overall unit volume decreased by 10%, primarily driven by declines in Consumer Beauty color cosmetics and body care brands.
  • Fragrance category experienced a mid-single digit percentage net revenue decline, with Prestige fragrance sales down $38.7 million due to high trade inventory levels and decelerating market trends.
  • Mass color cosmetics sales declined by $18.8 million due to poor performance in European markets and negative market trends in Brazil.
  • Mass body care sales declined by $9.3 million, impacted by competitive pricing in the deodorant market in Brazil.
  • Net revenues declined across all geographic regions: Americas (mid-single digit), EMEA (mid-single digit), and Asia Pacific (high-single digit).
  • Gross margin decreased by 100 basis points, primarily due to increased manufacturing and material costs and higher freight costs.
  • Operating income decreased by 22%, and operating margin declined by 250 basis points.
  • Consumer Beauty segment reported an operating loss of $7.7 million, compared to an income of $14.0 million in the prior year, with operating loss margin decreasing to 1.5% from 2.5%.
  • Net income attributable to Coty Inc. decreased by 18%.
  • Diluted EPS decreased from $0.09 to $0.07.
  • A decline in Coty's Class A shares in August 2025 triggered a $53.9 million cash payment for Hedge Valuation Adjustments on forward repurchase contracts.

Risks

  • Ability to successfully implement strategic priorities and compete effectively in the beauty industry within expected timeframes.
  • Anticipating and responding to rapidly changing market trends and consumer preferences, and market acceptance of new products.
  • Impact of future impairments on assets.
  • Managerial, transformational, operational, regulatory, legal, and financial risks, including managing multiple initiatives simultaneously.
  • Timing, costs, and impacts of divestitures and future acquisitions, new licenses, and joint ventures.
  • Increased competition, consolidation among retailers, shifts in distribution channels, and changes in the retail environment.
  • Ability to obtain, maintain, and protect intellectual property and defend against infringement claims.
  • Dependence on certain licenses, especially in the fragrance category, and ability to renew them on favorable terms.
  • Dependence on entities performing outsourced functions and third-party manufacturers/suppliers.
  • Administrative and product development difficulties in meeting expected timing of market expansions and product launches.
  • Changes in demand due to declining global or regional economic conditions, consumer confidence, or spending.
  • Global political and economic uncertainties, disruptions, or major regulatory/policy changes, including the war in Ukraine and armed conflict in the Middle East.
  • Currency exchange rate volatility, currency devaluation, and inflation.
  • Ability to implement and maintain pricing actions to mitigate increased costs and inflationary pressures.
  • Number, type, outcomes, and costs of current or future legal, compliance, tax, regulatory, or administrative proceedings, investigations, and litigation, including product liability cases (asbestos and talc-related litigation).
  • Disruptions in the availability and distribution of raw materials and components, and supply chain challenges.
  • Ability to adapt business to climate change concerns and respond to increasing environmental, social, and governance (ESG) regulations.
  • Restrictions imposed by license agreements, credit facilities, and other material contracts, and ability to generate cash flow to repay debt.
  • Increasing dependency on information technology and protection against service interruptions, data corruption, cyber-attacks, or security breaches.
  • Ability to attract and retain key personnel and impact of senior management transitions.
  • Distribution and sale by third parties of counterfeit and/or gray market products.
  • Impact of ongoing strategic transformation on relationships with key customers and suppliers.
  • Relationship with JAB Beauty B.V. as majority stockholder and potential conflicts of interest or litigation.
  • Relationship with KKR as an investor in Wella and potential conflicts of interest or litigation.
  • Future sales of a significant number of shares by the majority stockholder or the perception of such sales.
  • Brazilian tax assessments totaling approximately $386.9 million (R$2.0 billion) as of September 30, 2025, with ongoing judicial processes and required surety bonds/cash deposits of $186.0 million.

Future Outlook

Management expects reported net revenue for the second quarter of fiscal 2026 to be roughly flat year-over-year, including a low to mid-single digit percentage benefit from foreign exchange. Gross margin for Q2 fiscal 2026 is anticipated to be pressured by lower sales and tariff impacts, with some easing in the second half of fiscal 2026 due to mitigation efforts. Reported net revenue for the second half of fiscal 2026 is projected to return to growth, supported by major launches in both Prestige and Consumer Beauty segments and more favorable comparisons. The company is re-accelerating cost reduction efforts to achieve approximately $80.0 million in savings in fiscal 2026. Dividends on common stock are expected to remain suspended until the Net debt to Adjusted EBITDA target of 2x is approached.

Management Comments

  • "We have sharpened our priorities to capitalize on structural tailwinds in the fragrance market."
  • "We are leveraging our leadership in fragrance innovation, licensing, and manufacturing to expand across price points, from mass to ultra-premium and across scenting formats."
  • "We have launched a comprehensive strategic review of our Consumer Beauty business which will focus specifically on its mass color cosmetics business and its distinct Brazil business... with the objective of maximizing long-term value and strengthening the balance sheet."
  • "We will continue to implement our plans to unlock material opportunities in ultra-premium fragrances, mists and broader scenting."
  • "We are optimizing our supply chain to enhance resilience and agility in response to changing tariff environments."
  • "We expect that any increases in our cost of goods sold will be balanced with minimal price adjustments to ensure competitiveness."
  • "We are closely monitoring developments, evaluating potential impacts, and proactively taking steps to mitigate adverse effects on our business."
  • "We believe fragrances will remain a structurally advantageous category, supported by beauty category-leading brand loyalty, strong consumer demand, increasing usage, broader price points and formats, and expanding global penetration."
  • "With a slate of new launches scheduled for fiscal 2026 and beyond, we believe that our prestige fragrances are strategically positioned to achieve sustained growth and strong momentum across key markets."
  • "We are re-accelerating our cost reduction efforts to deliver savings of approximately $80.0 million in fiscal 2026."
  • "We remain focused on deleveraging our balance sheet using cash flows generated from our operations."
  • "Our 25.84% investment in Wella continues to give us the opportunity for further permanent debt reductions when our equity position is divested."
  • "We believe it has meritorious defenses and it has not recognized a loss for these [Brazilian tax] assessments as the Company does not believe a loss is probable."

Industry Context

Coty operates in a global beauty market with structural tailwinds in the fragrance category, which it aims to capitalize on by leveraging its leadership in innovation and licensing. However, the company faces challenges in mass color cosmetics and body care, particularly in European and Brazilian markets, where demand for its products is weakening amidst competitive pricing. The broader industry is experiencing shifts towards digital and prestige channels, and companies are navigating global supply chain disruptions, inflationary pressures, and geopolitical uncertainties. Coty's strategic review of its Consumer Beauty business reflects a broader industry trend of companies optimizing portfolios to focus on higher-growth, higher-margin segments.

Comparison to Industry Standards

  • The filing indicates that Coty's fragrance category experienced a mid-single digit percentage net revenue decline despite growth in the overall fragrance market, suggesting underperformance relative to the broader market trend.
  • The decline in mass color cosmetics and body care revenues, particularly in European and Brazilian markets, points to challenges in competitive positioning and market demand for Coty's specific brands within these segments, potentially lagging behind competitors or overall market trends in those regions.
  • The company's efforts to optimize its supply chain and accelerate dual sourcing for prestige products are in line with industry-wide responses to global supply chain challenges and tariff impacts, aiming to enhance resilience and agility.

Legal Proceedings

  • The company is a defendant in numerous civil actions alleging asbestos contamination in cosmetic talcum powder products, with settlement values and costs likely to increase due to rising case numbers and evolving litigation.
  • Brazilian subsidiaries face tax assessments from local, state, and federal authorities totaling approximately $386.9 million (R$2.0 billion) as of September 30, 2025, for improperly registered ICMS and calculated IPI taxes from 2016-2020.
  • Surety bonds and cash deposits totaling $186.0 million have been provided to guarantee payment if Brazilian tax cases are resolved against Coty, with additional surety bonds of $83.8 million and $65.3 million for other ongoing cases.
  • A judicial case regarding an additional claim for fees over a tax incentive ('the Protege Fee') in Gois State is expected to be heard in the second half of the current fiscal year, with a related tax enforcement case also in judicial court.

Related Party Transactions

  • JAB Beauty B.V., the company's largest stockholder, beneficially owns approximately 54% of Coty's Class A Common Stock.
  • The company has a performance guarantee for a real estate lease assigned to JAB Partners LLP, with a maximum potential future payment of approximately $3.1 million if the assignee defaults.
  • Coty holds a 25.84% equity investment in Wella (an affiliate of KKR), which is accounted for at fair value.
  • The company recognized a gain of $3.4 million from post-closing adjustments related to the sale of the Wella Business.
  • Coty provides manufacturing arrangements to Wella, earning $1.6 million in fees for the three months ended September 30, 2025.
  • Coty provides management, consulting, and financial services to Wella, earning $0.4 million in fees for the three months ended September 30, 2025.
  • Accounts receivable from Wella were $41.5 million and accounts payable to Wella were $0.4 million as of September 30, 2025.
  • Accrued long-term payables due to Wella were $35.2 million as of September 30, 2025.
  • Sublease income from Wella was $1.3 million for the three months ended September 30, 2025.

Stakeholder Impact

  • **Shareholders**: Negative impact from decreased net income and diluted EPS, and a decline in Class A share price triggering payments for forward repurchase contracts. The strategic review of Consumer Beauty and debt refinancing could offer long-term value creation but introduce near-term uncertainty. Dividend suspension continues.
  • **Employees**: Impacted by the Fixed Cost Reduction Plan, which involves restructuring and business structure realignment costs, potentially leading to severance and changes in roles.
  • **Customers**: Potential impact from competitive pricing actions in certain markets (e.g., Brazil deodorant market) and changes in product offerings as a result of the Consumer Beauty strategic review.
  • **Suppliers**: Supply chain optimization efforts, including diversified sourcing strategies and regionalization, may shift demand among suppliers.
  • **Creditors**: Debt refinancing activities aim to optimize the maturity profile and reduce interest costs, which is generally positive. The company remains in compliance with debt covenants, providing stability.

Next Steps

  • Continue the comprehensive strategic review of the Consumer Beauty business (mass color cosmetics and Brazil business) to assess partnerships, divestitures, spin-offs, and other strategic actions.
  • Implement plans to unlock opportunities in ultra-premium fragrances, mists, and broader scenting.
  • Re-accelerate cost reduction efforts to deliver approximately $80.0 million in savings in fiscal 2026.
  • Continue optimizing the supply chain to enhance resilience and agility, including accelerating dual sourcing for entry-level prestige products and evaluating expanded regionalization strategies.
  • Monitor and mitigate the impact of tariff increases, with an estimated $30.0 million in costs expected in fiscal 2026 and $5.0 million in Q1 fiscal 2027.
  • Address ongoing legal proceedings, including asbestos-related litigation and Brazilian tax assessments, vigorously defending cases and pursuing favorable judicial/administrative decisions.
  • Consider future resumption of common stock dividends once the Net debt to Adjusted EBITDA target of 2x is approached.
  • Continue to pursue opportunities to permanently reduce debt, including potential divestiture of the Wella equity position.

Key Dates

DateDescription
2014-02-01Board authorized the company to repurchase Class A Common Stock under approved repurchase programs.
2016-02-03Board authorized the company to repurchase up to $500.0 million of its Class A Common Stock.
2017-03-27Series A Preferred Stock subscription agreement entered into with Lambertus J.H. Becht; exchange right expired on March 27, 2024.
2018-04-05Company entered into an amended and restated credit agreement (the '2018 Coty Credit Agreement').
2020-04-29Board of Directors suspended the payment of dividends on Common Stock.
2021-04-21Company issued $900.0 million of 5.00% senior secured notes due 2026 (the '2026 Dollar Senior Secured Notes').
2021-06-16Company issued 700.0 million of 3.875% senior secured notes due 2026 (the '2026 Euro Senior Secured Notes').
2021-08-27KKR Aggregator sold 146,057 shares of Series B Preferred Stock to HFS.
2021-11-30Company issued $500.0 million of 4.75% senior secured notes due 2029 ('2029 Dollar Senior Secured Notes').
2021-12-22Company entered into an agreement with KKR Bidco related to post-closing adjustments for the Wella Business sale.
2022-12-01Company entered into forward repurchase contracts to hedge for potential $196.0 million share buyback program in 2025.
2023-05-04Company granted CEO Sue Nabi a one-time award of 10,416,667 RSUs and will grant 10,416,665 PRSUs in five equal tranches over five years.
2023-07-26Company issued $750.0 million of 6.625% senior secured notes due 2030 ('2030 Dollar Senior Secured Notes').
2023-09-19Company issued 500.0 million of 5.750% senior secured notes due 2028 ('2028 Euro Senior Secured Notes').
2023-11-13Board increased the company's share repurchase authorization by an additional $600.0 million.
2023-11-01Company entered into forward repurchase contracts to hedge for potential $294.0 million share buyback program in 2026.
2024-05-30Company issued 500.0 million of 4.50% senior secured notes due 2027 ('2027 Euro Senior Secured Notes').
2024-09-01As of this date, each of the Senior Secured Notes achieved an investment grade rating from two ratings agencies, triggering collateral release and covenant suspension provisions.
2024-10-01Price of Coty's Class A shares declined below the threshold for November 2023 forward repurchase contracts, resulting in a $61.8 million cash payment to counterparties.
2024-11-01Company entered into agreements for a temporary contractual amendment to the Hedge Valuation Adjustment, resulting in a refund of $61.8 million from counterparties.
2024-12-01Company entered into an agreement to extend the maturity date of the December 2022 forward repurchase contracts by one year.
2025-02-01Price of Coty's Class A shares declined below the threshold for forward repurchase contracts, resulting in a $191.1 million cash payment to counterparties.
2025-04-24Company announced a new Fixed Cost Reduction Plan to strengthen its operating model and simplify its fixed cost structure.
2025-08-01Price of Coty's Class A shares declined below the threshold for forward repurchase contracts, resulting in a $53.9 million cash payment to counterparties.
2025-09-30End of the quarterly period covered by this report.
2025-10-15Company issued $900.0 million of 5.600% senior notes due 2031 in a private offering.
2025-10-17Company used proceeds from the 2031 Senior Notes offering to redeem the remaining $350.0 million of 2026 Dollar Senior Secured Notes and 450.0 million (approximately $520.0 million) of 2026 Euro Senior Secured Notes.
2025-10-24874,617,676 shares of Class A Common Stock were outstanding.
2025-11-05Date of filing of this Quarterly Report on Form 10-Q.

Recommendation

hold

Coty's Q1 fiscal 2026 results show significant declines in revenue, operating income, and net income, indicating a challenging period. While the strategic review of the Consumer Beauty business and recent debt refinancing are prudent long-term moves to optimize the portfolio and balance sheet, the immediate financial performance is weak. The company faces ongoing headwinds from market trends, tariff costs, and substantial legal/tax contingencies in Brazil. The outlook for Q2 is flat, with a return to growth only expected in the second half of fiscal 2026. A seasoned investor would likely maintain a 'hold' position, awaiting clearer signs of successful execution of the strategic review, sustained revenue growth, and effective mitigation of cost pressures and legal risks before considering a more aggressive stance.

Keywords

Beauty, Fragrance, Cosmetics, Skincare, Consumer Beauty, Prestige Beauty, SEC Filing, 10-Q, Financial Results, Revenue, Operating Income, Net Income, Debt Refinancing, Strategic Review, Tariffs, Share Repurchase, Wella, Brazil Market, Supply Chain, Cost Reduction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.